
Sarae L. Bausch
Examiner (ID: 12480, Phone: (571)272-2912 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1699 |
| Total Applications | 1041 |
| Issued Applications | 199 |
| Pending Applications | 206 |
| Abandoned Applications | 655 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17314962
[patent_doc_number] => 20210404010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => DETECTION OF COLORECTAL NEOPLASMS
[patent_app_type] => utility
[patent_app_number] => 17/027110
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29122
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17027110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/027110 | DETECTION OF COLORECTAL NEOPLASMS | Sep 20, 2020 | Abandoned |
Array
(
[id] => 16557546
[patent_doc_number] => 20210002694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => Methods of Administering 3,4-Diaminopyridine
[patent_app_type] => utility
[patent_app_number] => 17/025918
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17025918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/025918 | Methods of Administering 3,4-Diaminopyridine | Sep 17, 2020 | Abandoned |
Array
(
[id] => 16557545
[patent_doc_number] => 20210002693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => Methods of Administering 3,4-Diaminopyridine
[patent_app_type] => utility
[patent_app_number] => 17/025909
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17025909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/025909 | Methods of Administering 3,4-Diaminopyridine | Sep 17, 2020 | Abandoned |
Array
(
[id] => 17946183
[patent_doc_number] => 20220333200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => IN VITRO FERTILISATION (IVF) EMBRYO VIABILITY AND QUALITY ASSAY
[patent_app_type] => utility
[patent_app_number] => 17/642510
[patent_app_country] => US
[patent_app_date] => 2020-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642510
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/642510 | IN VITRO FERTILISATION (IVF) EMBRYO VIABILITY AND QUALITY ASSAY | Sep 15, 2020 | Pending |
Array
(
[id] => 16541359
[patent_doc_number] => 20200407772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => Methods of Administering 3,4-Diaminopyridine
[patent_app_type] => utility
[patent_app_number] => 17/009250
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44262
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17009250
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/009250 | Methods of administering 3,4-diaminopyridine | Aug 31, 2020 | Issued |
Array
(
[id] => 16541360
[patent_doc_number] => 20200407773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => Methods of Administering 3,4-Diaminopyridine
[patent_app_type] => utility
[patent_app_number] => 17/009261
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17009261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/009261 | Methods of Administering 3,4-Diaminopyridine | Aug 31, 2020 | Abandoned |
Array
(
[id] => 16673510
[patent_doc_number] => 20210062273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => METHODS FOR RAPID DETECTION OF EGFR VARIANTS AND AMPLIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/002145
[patent_app_country] => US
[patent_app_date] => 2020-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17002145
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/002145 | METHODS FOR RAPID DETECTION OF EGFR VARIANTS AND AMPLIFICATION | Aug 24, 2020 | Abandoned |
Array
(
[id] => 17830543
[patent_doc_number] => 20220267847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => CRISPR MULTI-TARGET DETECTION METHOD AND TEST KIT THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/629545
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629545 | CRISPR MULTI-TARGET DETECTION METHOD AND TEST KIT THEREFOR | Jul 23, 2020 | Pending |
Array
(
[id] => 17541251
[patent_doc_number] => 11306364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/928164
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 7001
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16928164
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/928164 | None | Jul 13, 2020 | Issued |
Array
(
[id] => 17897404
[patent_doc_number] => 20220307066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => AN ENZYMATIC ASSAY TO MEASURE LONG-TERM ADHERENCE TO PRE EXPOSURE PROPHYLAXIS AND ANTIRETROVIRAL THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/618323
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618323
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618323 | AN ENZYMATIC ASSAY TO MEASURE LONG-TERM ADHERENCE TO PRE EXPOSURE PROPHYLAXIS AND ANTIRETROVIRAL THERAPY | Jun 11, 2020 | Pending |
Array
(
[id] => 17792548
[patent_doc_number] => 20220251639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => OLIGONUCLEOTIDE, OMICS ANALYSIS METHOD, AND OMICS ANALYSIS KIT
[patent_app_type] => utility
[patent_app_number] => 17/611536
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611536 | OLIGONUCLEOTIDE, OMICS ANALYSIS METHOD, AND OMICS ANALYSIS KIT | May 18, 2020 | Pending |
Array
(
[id] => 18222127
[patent_doc_number] => 20230061121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHODS CONCERNING ONGOING TREATMENT FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 17/609985
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609985
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609985 | METHODS CONCERNING ONGOING TREATMENT FOR CANCER | May 14, 2020 | Pending |
Array
(
[id] => 17790393
[patent_doc_number] => 20220249484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => METHODS FOR PREDICTING RESPONSIVENESS OF CANCER TO FERROPTOSIS-INDUCING THERAPIES
[patent_app_type] => utility
[patent_app_number] => 17/611805
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611805 | METHODS FOR PREDICTING RESPONSIVENESS OF CANCER TO FERROPTOSIS-INDUCING THERAPIES | May 14, 2020 | Pending |
Array
(
[id] => 16437472
[patent_doc_number] => 20200354798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => METHODS FOR DETERMINING TUMOR MICROSATELLITE INSTABILITY
[patent_app_type] => utility
[patent_app_number] => 16/869484
[patent_app_country] => US
[patent_app_date] => 2020-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869484
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869484 | METHODS FOR DETERMINING TUMOR MICROSATELLITE INSTABILITY | May 6, 2020 | Abandoned |
Array
(
[id] => 17838147
[patent_doc_number] => 20220275452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => TUMOR MARKER STAMP-EP7 BASED ON METHYLATED MODIFICATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/594791
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594791
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594791 | TUMOR MARKER STAMP-EP7 BASED ON METHYLATED MODIFICATION AND USE THEREOF | Apr 28, 2020 | Pending |
Array
(
[id] => 18340099
[patent_doc_number] => 20230132048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHOD FOR PROVIDING INFORMATION ABOUT THERAPEUTIC RESPONSE TO ANTICANCER IMMUNOTHERAPY, AND KIT USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/611988
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611988
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611988 | METHOD FOR PROVIDING INFORMATION ABOUT THERAPEUTIC RESPONSE TO ANTICANCER IMMUNOTHERAPY, AND KIT USING SAME | Apr 27, 2020 | Pending |
Array
(
[id] => 17897347
[patent_doc_number] => 20220307009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => ISOLATED NUCLEIC ACID BINDING DOMAINS
[patent_app_type] => utility
[patent_app_number] => 17/594277
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594277
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594277 | Isolated nucleic acid binding domains | Apr 26, 2020 | Issued |
Array
(
[id] => 20687960
[patent_doc_number] => 12618098
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-05
[patent_title] => Proximity-driven activation of CRISPR-Cas systems for detection of diverse molecular analytes
[patent_app_type] => utility
[patent_app_number] => 17/606225
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 15
[patent_no_of_words] => 9901
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 246
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606225
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606225 | Proximity-driven activation of CRISPR-Cas systems for detection of diverse molecular analytes | Apr 26, 2020 | Issued |
Array
(
[id] => 17642370
[patent_doc_number] => 20220170108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => METHOD FOR DIAGNOSING CANCER USING CFDNA
[patent_app_type] => utility
[patent_app_number] => 17/594063
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594063
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594063 | METHOD FOR DIAGNOSING CANCER USING CFDNA | Apr 2, 2020 | Pending |
Array
(
[id] => 17657512
[patent_doc_number] => 20220177977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => APPARATUS, SYSTEM AND METHOD
[patent_app_type] => utility
[patent_app_number] => 17/598324
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598324 | APPARATUS, SYSTEM AND METHOD | Mar 25, 2020 | Pending |